Isis Pharma to get expanded US patent for single-stranded RNAi technology
Saturday, September 12, 2009 11:00 IST Cambridge
Isis Pharmaceuticals, Inc and Alnylam Pharmaceuticals, Inc announced that the United States Patent and Trademark Office (US PTO) has allowed an Isis patent application that further expands the scope of the 'Crooke' patent estate.